Skip to main content
. 2021 May 7;2021(5):CD010876. doi: 10.1002/14651858.CD010876.pub3

ACTIVE AFTER TAVR 2017.

Study name A pragmatiC sTrategy to Promote actIVity and Enhance Quality of Life AFTER Transcatheter Aortic Valve Replacement (ACTIVE AFTER TAVR): a pilot study
Methods Parallel‐assignment RCT
Participants Subjects who have been treated commercially with TAVR with a SAPIEN 3 valve and are being discharged to home
Interventions Active comparator: no resistance exercise and no activity goal arm; blinded use of Fitbit with no daily activity goal and no resistance exercises
Experimental: resistance exercise and activity goal arm; unblinded use of Fitbit with daily activity goal (steps per day) and resistance exercises
Outcomes Primary outcome measures
  • Average daily steps [Time Frame: randomization to 6 weeks, average daily steps over the intervention period]

  • Short physical performance battery score [Time Frame: 6‐week value, adjusted for baseline value, combination of gait speed, balance test, and chair‐to‐stand test at end of intervention]

  • Quality of life as measured with KCCQ Overall Summary Score [Time Frame: 6‐week value, adjusted for baseline value, KCCQ overall summary score]


Secondary outcome measures
  • 5‐meter gait time at end of intervention period [Time Frame: randomisation to 6 weeks, 5‐meter gait time at end of intervention period, adjusted for baseline]

  • Chair sit‐to‐stand test [Time Frame: 6‐week value, adjusted for baseline value, time to complete 5 chair stands]

  • Balance test score at end of intervention period [Time Frame: randomisation to 6 weeks, balance test score at end of intervention period, adjusted for baseline]

  • 6‐minute walk [Time Frame: 6‐week value, adjusted for baseline value, 6‐minute walk distance at end of intervention period]

  • Handgrip [Time Frame: 6‐week value, adjusted for baseline value, handgrip strength'

  • Average number of hours per day with 250 or more steps [Time Frame: randomisation to 6 weeks, average number of hours per day with 250 or more steps over intervention period]

  • Average global physical health as assessed by PROMIS Global Health 10 Short Form [Time Frame: randomisation to 6 weeks, average global physical health as assessed by PROMIS Global Health 10 Short Form over intervention period]

  • Average global mental health as assessed by PROMIS Global Health 10 Short Form [Time Frame: randomisation to 6 weeks, average global mental health as assessed by PROMIS Global Health 10 Short Form over intervention period]

  • Physical function as assessed by NIH PROMIS computerised adaptive test [Time Frame: randomisation to 6 weeks, physical function as assessed by NIH PROMIS computerised adaptive test, adjusted for baseline]

  • Depression as assessed by NIH PROMIS computerised adaptive test [Time Frame: randomisation to 6 weeks, depression as assessed by NIH PROMIS computerised adaptive test, adjusted for baseline]

  • Fatigue as assessed by NIH PROMIS computerised adaptive test [Time Frame: randomisation to 6 weeks, fatigue as assessed by NIH PROMIS computerised adaptive test, adjusted for baseline]

  • Dyspnoea as assessed by NIH PROMIS computerised adaptive test [Time Frame: randomisation to 6 weeks, dyspnoea as assessed by NIH PROMIS computerised adaptive test, adjusted for baseline]

  • Daily active minutes (total) [Time Frame: randomisation to 6 weeks, average daily active minutes (total)

  • Daily active minutes of moderate to high intensity [Time Frame: randomisation to 6 weeks, average daily minutes of moderate to high intensity]

  • Sedentary minutes [Time Frame: randomisation to 6 weeks, average daily sedentary minutes]

  • Daily steps [Time Frame: 6 weeks post baseline to end of study, average daily steps]

  • Daily active minutes (total) [Time Frame: 6 weeks post baseline to end of study, average daily active minutes (total)]

  • Daily active minutes of moderate to high intensity [Time Frame: 6 weeks post baseline to end of study, average daily active minutes of moderate to high intensity]

  • Daily sedentary minutes [Time Frame: 6 weeks post baseline to end of study, average daily sedentary minutes]

  • KCCQ Overall Summary Score [Time Frame: 6 weeks post baseline to end of study, KCCQ overall summary score, adjusted for baseline]

  • Global physical health [Time Frame: 6 weeks post baseline to end of study, global physical health as assessed by PROMIS Global Health 10 Short Form, adjusted for baseline]

  • Global mental health [Time Frame: 6 weeks post baseline to end of study, global mental health as assessed by PROMIS Global Health 10 Short Form, adjusted for baseline]

Starting date 7 November 2017
Contact information Brian Lindman, Associate Professor, Vanderbilt University Medical Center
Notes Estimated enrolment: 85 participants. Estimated study completion date: August 2020
Location: Massachusetts General Hospital, Dartmouth‐Hitchcock Medical Center, Atlantic Health ‐ Morristown Medical Center, Vanderbilt University Medical Center, University of Utah